Sort
46,585 grants matching “heart failure”
Paradoxical Effects of NF-kB in Ischemia; Novel Polymeric Gene Silencing in vivo
$630,019W Keith Jones · University Of Cincinnati · R01 · FY2009 · HL
A-Adrenergic Axis in Hypertrophy and Heart Failure
$629,961Gerald W. Dorn · University Of Cincinnati · P50 · FY2009 · HL
Hormone and Cytokine Regulation of Endotoxin Injury
$629,952Siobhan A Corbett · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2010 · GM
Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis
$629,898Paul Werner Buehler · University Of Maryland Baltimore · R01 · FY2024 · HL
Heart Failure Group Appointments: Rehospitalization Prevention Clinical Trial
$629,787Carol E Smith · University Of Kansas Medical Center · R01 · FY2008 · HL
Protocolized Goal-directed Resuscitation of Septic Shock to Prevent AKI
$629,763John A Kellum · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DK
Heart Failure Disparities in Native Hawaiians
$629,746Marjorie K Mau · University Of Hawaii At Manoa · U01 · FY2006 · HL
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
$629,716Yang K Xiang · University Of California At Davis · R01 · FY2022 · HL
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
$629,642Brian Jesse Debosch · Washington University · R01 · FY2022 · HL
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
$629,586Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2025 · AR
Discovery of modifier genes in cardiomyopathy
$629,555Jeffrey A Towbin · University Of Tennessee Health Sci Ctr · R01 · FY2022 · HL
Discovery of modifier genes in cardiomyopathy
$629,555Jeffrey A Towbin · University Of Tennessee Health Sci Ctr · R01 · FY2020 · HL
Discovery of modifier genes in cardiomyopathy
$629,555Jeffrey A Towbin · University Of Tennessee Health Sci Ctr · R01 · FY2021 · HL
Discovery of modifier genes in cardiomyopathy
$629,555Jeffrey A Towbin · University Of Tennessee Health Sci Ctr · R01 · FY2023 · HL
Cardiovascular Consequences of Duchenne and Becker Muscular Dystrophinopathies
$629,535Melissa A.h. Witman · University Of Delaware · R01 · FY2021 · HL
Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
$629,432Christoph Hornik · Duke University · R01 · FY2024 · HD
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
$629,383Stephen F Vatner · Rbhs-New Jersey Medical School · R01 · FY2015 · HL
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
$629,333Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2010 · HL
Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescue
$629,306Michael John Davis · University Of Missouri-Columbia · R01 · FY2023 · HL
Control of cardiomyocyte cell cycle by REST in heart failure and regeneration
$629,301Bin Zhou · Albert Einstein College Of Medicine · R01 · FY2022 · HL
Improving Hypertension Medication Adherence for Older Adults
$629,288Jeannie Kim Lee · University Of Arizona · R01 · FY2024 · NR
Reawakening cardiomyocyte proliferation from structural mediated quiescence
$629,220James Francis Martin · Baylor College Of Medicine · R01 · FY2025 · HL
Research and Development of Effective Therapies for Patients with Rare Tumors
$629,166Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
ARIC Neurocognitive Study (ARIC-NCS)
$629,145David J Couper · Univ Of North Carolina Chapel Hill · U01 · FY2012 · HL
Resilience, cultural alignment, and social support in brain aging: the Strong Heart Study
$629,112Astrid M Suchy-Dicey · Huntington Medical Research Institutes · R01 · FY2024 · AG